Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 152

1.

Use of Plasmodium falciparum culture-adapted field isolates for in vitro exflagellation-blocking assay.

Leba LJ, Musset L, Pelleau S, Estevez Y, Birer C, Briolant S, Witkowski B, Ménard D, Delves MJ, Legrand E, Duplais C, Popovici J.

Malar J. 2015 Jun 4;14:234. doi: 10.1186/s12936-015-0752-x.

2.

Development of a single nucleotide polymorphism barcode to genotype Plasmodium vivax infections.

Baniecki ML, Faust AL, Schaffner SF, Park DJ, Galinsky K, Daniels RF, Hamilton E, Ferreira MU, Karunaweera ND, Serre D, Zimmerman PA, Sá JM, Wellems TE, Musset L, Legrand E, Melnikov A, Neafsey DE, Volkman SK, Wirth DF, Sabeti PC.

PLoS Negl Trop Dis. 2015 Mar 17;9(3):e0003539. doi: 10.1371/journal.pntd.0003539. eCollection 2015 Mar.

3.

COIL: a methodology for evaluating malarial complexity of infection using likelihood from single nucleotide polymorphism data.

Galinsky K, Valim C, Salmier A, de Thoisy B, Musset L, Legrand E, Faust A, Baniecki ML, Ndiaye D, Daniels RF, Hartl DL, Sabeti PC, Wirth DF, Volkman SK, Neafsey DE.

Malar J. 2015 Jan 19;14(1):4. [Epub ahead of print]

4.

Lower vitamin D levels are associated with higher systemic lupus erythematosus activity, but not predictive of disease flare-up.

Schoindre Y, Jallouli M, Tanguy ML, Ghillani P, Galicier L, Aumaître O, Francès C, Le Guern V, Lioté F, Smail A, Limal N, Perard L, Desmurs-Clavel H, Le Thi Huong D, Asli B, Kahn JE, Sailler L, Ackermann F, Papo T, Sacré K, Fain O, Stirnemann J, Cacoub P, Leroux G, Cohen-Bittan J, Hulot JS, Lechat P, Musset L, Piette JC, Amoura Z, Souberbielle JC, Costedoat-Chalumeau N; Group PLUS.

Lupus Sci Med. 2014 Jun 7;1(1):e000027. doi: 10.1136/lupus-2014-000027. eCollection 2014.

5.

Effects of mefloquine use on Plasmodium vivax multidrug resistance.

Khim N, Andrianaranjaka V, Popovici J, Kim S, Ratsimbasoa A, Benedet C, Barnadas C, Durand R, Thellier M, Legrand E, Musset L, Menegon M, Severini C, Nour BY, Tichit M, Bouchier C, Mercereau-Puijalon O, Ménard D.

Emerg Infect Dis. 2014 Oct;20(10):1637-44. doi: 10.3201/eid2010.140411.

6.

Malaria on the Guiana Shield: a review of the situation in French Guiana.

Musset L, Pelleau S, Girod R, Ardillon V, Carvalho L, Dusfour I, Gomes MS, Djossou F, Legrand E.

Mem Inst Oswaldo Cruz. 2014 Aug;109(5):525-33. Epub 2014 Aug 13.

7.

Systemic sclerosis and prevalence of monoclonal immunoglobulin.

Trad S, Nosbaum A, Musset L, Ghillani-Dalbin P, Launay D, Costedoat-Chalumeau N, Saadoun D, Cabane J, Hachulla E, Hanslik T, Frances C.

Autoimmun Rev. 2014 Dec;13(12):1189-94. doi: 10.1016/j.autrev.2014.08.016. Epub 2014 Aug 23. Review.

PMID:
25151977
8.

PegIFNα/ribavirin/protease inhibitor combination in severe hepatitis C virus-associated mixed cryoglobulinemia vasculitis.

Saadoun D, Resche Rigon M, Pol S, Thibault V, Blanc F, Pialoux G, Karras A, Bazin-Kara D, Cazorla C, Vittecoq D, Musset L, Peltier J, Decaux O, Ziza JM, Lambotte O, Cacoub P.

J Hepatol. 2015 Jan;62(1):24-30. doi: 10.1016/j.jhep.2014.08.015. Epub 2014 Aug 15.

PMID:
25135864
9.

Malaria on the Guiana Shield: a review of the situation in French Guiana.

Musset L, Pelleau S, Girod R, Ardillon V, Carvalho L, Dusfour I, Gomes MS, Djossou F, Legrand E.

Mem Inst Oswaldo Cruz. 2014 Aug 13;0:0. [Epub ahead of print]

10.

Novel clinical and diagnostic aspects of antineutrophil cytoplasmic antibodies.

Schulte-Pelkum J, Radice A, Norman GL, Lόpez Hoyos M, Lakos G, Buchner C, Musset L, Miyara M, Stinton L, Mahler M.

J Immunol Res. 2014;2014:185416. doi: 10.1155/2014/185416. Epub 2014 Jun 5. Review.

11.

From ANA-screening to antigen-specificity: an EASI-survey on the daily practice in European countries.

Damoiseaux J, Agmon-Levin N, Van Blerk M, Chopyak V, Eriksson C, Heijnen I, Herold M, Høgåsen K, Musset L, Radice A, Rego de Sousa MJ, Viander M, Shoenfeld Y.

Clin Exp Rheumatol. 2014 Jul-Aug;32(4):539-46. Epub 2014 Jun 30.

PMID:
24983380
12.

Emergence of resistance to atovaquone-proguanil in malaria parasites: insights from computational modeling and clinical case reports.

Cottrell G, Musset L, Hubert V, Le Bras J, Clain J; Atovaquone-Proguanil Treatment Failure Study Group.

Antimicrob Agents Chemother. 2014 Aug;58(8):4504-14. doi: 10.1128/AAC.02550-13. Epub 2014 May 27.

13.

Patterns of selection on Plasmodium falciparum erythrocyte-binding antigens after the colonization of the New World.

Yalcindag E, Rougeron V, Elguero E, Arnathau C, Durand P, Brisse S, Diancourt L, Aubouy A, Becquart P, D'Alessandro U, Fontenille D, Gamboa D, Maestre A, Ménard D, Musset L, Noya O, Veron V, Wide A, Carme B, Legrand E, Chevillon C, Ayala FJ, Renaud F, Prugnolle F.

Mol Ecol. 2014 Apr;23(8):1979-93.

PMID:
24834503
14.

Celiac disease diagnosis: impact of guidelines on medical prescription in France.

Pham BN, Musset L, Chyderiotis G, Olsson NO, Fabien N.

J Dig Dis. 2014 Aug;15(8):435-43. doi: 10.1111/1751-2980.12158.

PMID:
24825345
15.

Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin.

Allenbach Y, Drouot L, Rigolet A, Charuel JL, Jouen F, Romero NB, Maisonobe T, Dubourg O, Behin A, Laforet P, Stojkovic T, Eymard B, Costedoat-Chalumeau N, Campana-Salort E, Tournadre A, Musset L, Bader-Meunier B, Kone-Paut I, Sibilia J, Servais L, Fain O, Larroche C, Diot E, Terrier B, De Paz R, Dossier A, Menard D, Morati C, Roux M, Ferrer X, Martinet J, Besnard S, Bellance R, Cacoub P, Arnaud L, Grosbois B, Herson S, Boyer O, Benveniste O; French Myositis Network.

Medicine (Baltimore). 2014 May;93(3):150-7. doi: 10.1097/MD.0000000000000028.

PMID:
24797170
16.

Analysis of autoantibodies to 3-hydroxy-3-methylglutaryl-coenzyme A reductase using different technologies.

Musset L, Miyara M, Benveniste O, Charuel JL, Shikhman A, Boyer O, Fowler R, Mammen A, Phillips J, Mahler M.

J Immunol Res. 2014;2014:405956. doi: 10.1155/2014/405956. Epub 2014 Mar 5.

17.

Low titers of serum antibodies inhibiting hemagglutination predict fatal fulminant influenza A(H1N1) 2009 infection.

Guihot A, Luyt CE, Parrot A, Rousset D, Cavaillon JM, Boutolleau D, Fitting C, Pajanirassa P, Mallet A, Fartoukh M, Agut H, Musset L, Zoorob R, Kirilovksy A, Combadière B, van der Werf S, Autran B, Carcelain G; FluBAL Study Group.

Am J Respir Crit Care Med. 2014 May 15;189(10):1240-9. doi: 10.1164/rccm.201311-2071OC.

PMID:
24646009
18.

Th1 response and systemic treg deficiency in inclusion body myositis.

Allenbach Y, Chaara W, Rosenzwajg M, Six A, Prevel N, Mingozzi F, Wanschitz J, Musset L, Charuel JL, Eymard B, Salomon B, Duyckaerts C, Maisonobe T, Dubourg O, Herson S, Klatzmann D, Benveniste O.

PLoS One. 2014 Mar 4;9(3):e88788. doi: 10.1371/journal.pone.0088788. eCollection 2014.

19.

Chronic malaria revealed by a new fluorescence pattern on the antinuclear autoantibodies test.

Hommel B, Charuel JL, Jaureguiberry S, Arnaud L, Courtin R, Kassab P, Prendki V, Paris L, Ghillani-Dalbin P, Thellier M, Caumes E, Amoura Z, Mazier D, Musset L, Buffet P, Miyara M.

PLoS One. 2014 Feb 13;9(2):e88548. doi: 10.1371/journal.pone.0088548. eCollection 2014. Erratum in: PLoS One. 2014;9(3):e92361.

20.

Exploring necrotizing autoimmune myopathies with a novel immunoassay for anti-3-hydroxy-3-methyl-glutaryl-CoA reductase autoantibodies.

Drouot L, Allenbach Y, Jouen F, Charuel JL, Martinet J, Meyer A, Hinschberger O, Bader-Meunier B, Kone-Paut I, Campana-Salort E, Eymard B, Tournadre A, Musset L, Sibilia J, Marie I, Benveniste O, Boyer O; French Myositis Network [CN].

Arthritis Res Ther. 2014 Feb 3;16(1):R39. doi: 10.1186/ar4468.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk